Anordning ved stigerør,申请号NO19990006409-传众专利搜索

首页产品黄页商标征信

会员服务注册登录

法人/股东/高管

发明名称	Anordning ved stigerør
摘要
申请公布号	NO996409(A)	申请公布日期	2000.06.26
申请号	NO19990006409	申请日期	1999.12.22
申请人	NORSK HYDRO ASA	发明人	FRIISK, HARALD ARNT
分类号	E21B;E21B17/01;(IPC1-7):E21B17/01	主分类号	E21B
代理机构		代理人
主权项
地址

您可能感兴趣的专利

(s)-4-amino-n-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, use thereof in the preparation of medicaments for the treatment of cancer, processes for its preparation and intermediates useful in said processes

Menetelmä muoviputken valmistamiseksi

Menetelmä liuotinuuttoaltaan valmistamiseksi ja liuotinuuttoallas

PRINTED DEVICE WITH THREE DIMENSIONAL APPEARANCE

Einrichtung zur Erzeugung von Drehbewegungen, Vorrichtung sowie medizinische Leuchte

Acoplamiento amortiguador para estructuras flotantes

Kraftstofffördermodul mit Kraftstofffilter

Hot gas prominent pipe for use in exhaust system of automobile, has coolant arranged in tubes and made to flow through by hot gas, and thermoelectric generators arranged transverse along flow direction of hot gas in swivel bearing

System und Verfahren für die Drehmomentsteuerung in einem elektronischen Allradantrieb-Fahrzeug

Producto de combustible multietapas de circuito sencillo

Sensorik zur Layoutvalidierung eines Sauerstoffmoduls

CARBONYLATION PROCESS USING METAL-TRIDENTATE LIGAND CATALYSTS

Carbon electrode of the supercapacitor in the iodine solutions

Methods for the production of orthogonal trna aminoacyl trna synthetase pairs

Culture medium for maintaining pluripotent stem cells in an undifferentiated state

Use of 40-o-(2-hydroxyethyl)- rapamycin in the preparation of pharmaceutical compositions for treating solid excretory system tumours, solid pancreatic tumours and solid brain tumours

Strahlfalle zur Absorption der Strahlungsenergie unerwünschter Laserstrahlung

(-)-halofenate in crystalline solid and amorphous forms

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND USE THEREOF